The potential of manipulating a particular protein is being explored as a possible alternative to blood thinners, which are the standard of care for venous thromboembolism, but whose association with severe bleeding makes blood thinners an imperfect remedy.
The largest study ever conducted on the genetics of common, age-related bone disease has resulted in the identification of 153 new gene variants associated with the loss of bone mineral density, the strongest clinical risk factor for osteoporosis and a frequent cause of fractures.
Dr. Pierre Pluye, a Senior Investigator in the Centre for Clinical Epidemiology and Community Studies at the Lady Davis Institute, has been named 2017 Family Medicine Researcher of the Year by the College of Family Physicians of Canada.
In the most recent round of funding by the Canadian Institutes of Health Research, Dr. Stéphane Richard received a CIHR Foundation Grant worth $3.5 million over seven years.
A symposium honouring the late Dr. Mark Wainberg on November 2 will become an annual international event on emerging and complex infectious diseases.
A sapling and a bench were dedicated as a place of reflection and commemoration, as JGH staff joined famly members to memorialize the perinatal losses that occurred at the hospital over the past year.
Having become a leader in its field since its launch in 2012, the JGH’s Centre of Excellence in Thrombosis and Anticoagulation Care is preparing to occupy a newly renovated area, featuring a more comfortable space for patients and improved facilities for research and teaching.